Frontlight ResearchEarly access
Trial site
Wilmot Cancer Institute
- 7running trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer2 trials
- Aplastic anaemia1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 12 trials
- Early phase 11 trial
- Phase 21 trial
- Phase 2/31 trial
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- University of Rochester2 trials
- Bristol-Myers Squibb1 trial
- Danielle Wallace1 trial
Running trials
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Active, not recruiting
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Aplastic anaemia1 recruiting
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Prostate cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026